Geneva, March 23 -- International Clinical Trials Registry received information related to the study (EUCTR2025-000542-25-Outside-EU/EEA) titled 'A Study to Describe the Safety and Immunogenicity of 20vPnC in Infants in India and Taiwan' on March 9.
Study Type: Interventional clinical trial of medicinal product
Study Design:
Controlled: yes Randomised: yes Open: no Single blind: no Double blind: yes Parallel group: yes Cross over: no Other: no If controlled, specify comparator, Other Medicinial Product: yes Placebo: no Other: no Number of treatment arms in the trial: 2
Primary Sponsor: Pfizer Inc.
Condition:
Pneumococcal Disease
Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
Intervention:
Trade Name: Prev...